• The Business of Personalized Medicine Summit


    February 27, 2020
    AC Hotel San Francisco Airport/Oyster Point Waterfront
    South San Francisco, CA

Break through to personalized medicine business solutions at this one-of-a-kind thought leadership event for startups and established companies alike, which aims to address the critical complexities, trends, and opportunities impacting innovation and commercialization within the evolving personalized medicine marketplace

 


Interactive Panel Discussions to Address:


Featuring Key Executives From:
The capital raising landscape and lessons learned
Spotlight on gene and cell therapy as an innovative and evolving technology area
Capitalizing on the commercial potential of direct-to-consumer genetic testing
Strategies for operationalizing a personalized medicine program at the point of care
The promise behind AI for discovery, validation, diagnosis, and data sharing
Evolving business models for companion diagnostics
Ampersand Capital Partners
Analysis Group
Anthem, Inc.
Bruce Quinn Associates LLC
California Technology Council
Catalia Health
Colorado Center for Personalized Medicine
Delfi Diagnostics
Genentech, Inc.
Genome Medical, Inc.
HealthX Ventures
Illumina Ventures
IncellDx
Mustang Bio
Natera
Orig3n
San Francisco Business Times
Silicon Valley Bank
UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS)

Don't Take Our Word For It

Jane Doe
I really thought this was a terrific one-day event. You attracted a talented, experienced, interesting audience.
John Doe
I look forward to attending next year’s BPM. The consistently high quality of the speakers and topics is great.
Moe Peter
Fantastic job. Very much appreciated the conference and will attend again. I was very impressed by the quality of the speakers.

2017 Speakers

Sharing Their Knowledge With Others

Paul Billings, MD, PhD

Paul Billings, MD, PhD

Chief Medical Officer and Senior Vice President, Medical Affairs
Natera
Lisa Alderson, MBA

Lisa Alderson, MBA

Co-Founder and Chief Executive Officer
Genome Medical, Inc.
Frank Witney, PhD

Frank Witney, PhD

Operating Partner
Ampersand Capital Partners

Thank You To Our Sponsors